期刊文献+

盐酸坦洛新缓释胶囊制备工艺及其体外释放度的考察研究 被引量:7

An Exploring Research about Preparation Technology and Released Effect of Tamsulosion Hydrochloride Sustained-Released Capsules
原文传递
导出
摘要 目的研究盐酸坦洛新缓释胶囊的制备工艺并对其体外释放度进行考察。方法采用蔗糖空白丸芯作为载药基质,用苏丽丝和雅克宜作为包衣缓释材料、以羟丙甲纤维素E6作为致孔剂,用流化床底喷溶液上药法制备载药微丸,并进行缓释包衣。以释放度作为评价指标,通过单因素实验对处方影响因素进行考察,并对自制盐酸坦洛新缓释胶囊与市售制剂释放曲线进行比较。结果本试验所述制剂工艺可靠,能顺利制备盐酸坦洛新缓释胶囊,其体外释放与市售制剂相似,批间及批内重复性较好。结论本试验制得的盐酸坦洛新缓释胶囊具有良好的缓释效果,制备工艺合理,简单易行,可适合工业化生产。 OBJECTIVE To study the preparation technology of tamsulosion hydroehloride sustained-release capsules and investi- gate the release degree in vitro. METHODS The pellets containing tamsulosin hydrochloride were prepeared in the fluid-bed using bottom gush medicine. Then, it was coated with ethylcellulose aqueous dispersion (surelease) , and in the following procedures, water- based acrylic resin enteric system ( Acryl-EZE ) was used as coating material, hydroxypropylmethylcellulose E6 ( HPMC E6) was considered as porous agent by fluid-bed. Based on the release degree in vitro, prescription influence factors were evaluated, as well as drug releases curve was compared, according to the single factor experiment. RESULTS The preparation technology referred in our research was available to make tamsulosin hydrochloride sustained-release capsules, and drug release curve of self-made sustained-re- lease capsules was similar to the commercial one. Additionally, the products reproducibility of intra-batch and inter-batch was excel- lent. CONCLUSION The tamsulosin hydrochloride sustained-release capsules prepared in this study exhibited ideal sustained-re- lease characteristics in vitro. The formulation is reasonable and feasible. It is suitable for industrial production.
出处 《中国药学杂志》 CAS CSCD 北大核心 2016年第18期1586-1591,共6页 Chinese Pharmaceutical Journal
关键词 盐酸坦洛新 缓释胶囊 制剂处方工艺 缓释微丸 体外释放 tamsulosin hydrochloride sustained-release capsule pharmaceutical technology sustained-release pellets release in vitro
  • 相关文献

参考文献4

二级参考文献28

  • 1陈贤春,吴清,王玉蓉,李冀湘.关于溶出曲线比较和评价方法[J].中国医院药学杂志,2007,27(5):662-664. 被引量:66
  • 2许铁男.排尿障碍治疗药——坦舒洛辛(tamsulosin hydrochloride)[J].国外医药·合成药,生化,制剂分册,1996,17(2):113-113.
  • 3叶金朝 傅毅.良性前列腺增生治疗药坦洛新(tamsulosin)[J].国外医药合成药,生化,制剂分册,1999,20(3):152-152.
  • 4陈新谦,金有豫,汤光.新编药物学[M].第17版.北京:人民卫生出版社,2011.81.
  • 5Honda K, Nakagawa C. Alpha-1 adrenoceptor antagonist effects of the optical isomers of YM-12617 in rabbit lower urinary tractand prostate[J]. J Pharmacol Exp Ther , 1986,239(2) :512.
  • 6Soeishi Y, Kobori M H, Kobayshi S, et al. Sensitive method for the detn. of amsulosin in human plasma using HPLC with fluorescence detection[ J ]. J Chromatogr, 1990,533,291.
  • 7Matsushima H, Kamimura H, Soeishi Y, et al. Pharmcokinetics and plasma protein binding of tamsulcsin hydrochloride in rats,dogs and humans[J]. Drug Metab Dispos, 1998,26(3) :240.
  • 8Yasuhara M, Fujiwara J, Kitade S, et al. Effect of altered plasma protein binding on pharmcokinetics and pharmcodynamics of propranolol in rats after surgery: role of alpha-1-acid glycoprotein[J]. J Pharmacol Exp Ther, 1985,235(2) :513.
  • 9McDevitt DG, Frisk-Holmber M, Hollifield JW, et al. Effect of altered disopyramide binding on its pharmacologic response in rabbits[J]. Clin Pharmacol Ther, 1976,20(2) : 152.
  • 10Matsushirma H,Takanuki K,Kamimura H, et al. Highly sensitive method for the determination of tamsulosin hydrochloride in human plasma dialysate, plasma and urine by HPLC-electrospray tandem mass spectrometry[J]. J Chromatogr B : Biomed Appl,1997,695(2) :317.

共引文献158

同被引文献73

引证文献7

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部